Forte Biosciences (FBRX) Operating Margin (2017 - 2019)
Forte Biosciences' (FBRX) quarterly Operating Margin came in at 17377.78% in Q4 2019, up 19493333.0% year-on-year from N/an in Q4 2018, and down 128.65% on a QoQ basis from 7600.0% in Q3 2019.
Forte Biosciences (FBRX) Operating Margin (2017 - 2019) Analysis & Trends
Forte Biosciences (FBRX) has 3 years of Operating Margin data on file, last reported at 17377.78% in Q4 2019.
- On a quarterly basis, Operating Margin rose 19493333.0% year-over-year to 17377.78% in Q4 2019; TTM through Dec 2019 was 54855.56%, a 5460132.0% decrease from a year earlier, with the FY2019 full-year figure at 11288.89%, down 1103466.0% from the prior year.
- Operating Margin for Q4 2019 stood at 17377.78%, down from 7600.0% in the prior quarter.
- Over the last five years, Operating Margin for FBRX reached as high as 7.92% in Q3 2018 and fell as low as 212311.11% in Q4 2018.
- Historically, Operating Margin has averaged 94138.07% across 3 years, with a median of 97370.0% in 2017.
- Across the five-year window, Operating Margin sank 10544111 bps in 2018 and soared 19493333 bps in 2019, its largest moves.
- Year by year, Operating Margin stood at 106870.0% in 2017, then tumbled by 99 bps to 212311.11% in 2018, then surged by 92 bps to 17377.78% in 2019.
- Per Business Quant data, the three most recent Operating Margin figures were 17377.78% in Q4 2019, 7600.0% in Q3 2019, and 6988.89% in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Forte Biosciences | 174.08 Mn | 115.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -17,377.78% |
| Sep 30, 2019 | -7,600.00% |
| Jun 30, 2019 | -6,988.89% |
| Mar 31, 2019 | -187,455.56% |
| Dec 31, 2018 | -212,311.11% |
| Sep 30, 2018 | 7.92% |
| Jun 30, 2018 | -170,300.00% |
| Mar 31, 2018 | -142,733.33% |
| Dec 31, 2017 | -106,870.00% |
| Sep 30, 2017 | -97,370.00% |
| Jun 30, 2017 | -86,520.00% |